221 related articles for article (PubMed ID: 8330399)
1. Whole-blood cyclosporin G in renal transplant recipients determined by two immunoassays and liquid chromatography.
McBride JH; Kim SS; Danovitch GM; Rodgerson DO; Reyes AF; Ota MK
Clin Chem; 1993 Jul; 39(7):1415-9. PubMed ID: 8330399
[TBL] [Abstract][Full Text] [Related]
2. Analysis of whole-blood cyclosporin G by liquid chromatography in renal transplant recipients.
McBride JH; Kim SS
J Clin Lab Anal; 1995; 9(4):238-42. PubMed ID: 7562241
[TBL] [Abstract][Full Text] [Related]
3. Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplant recipients.
McBride JH; Kim SS; Rodgerson DO; Reyes AF; Ota MK
Clin Chem; 1992 Nov; 38(11):2300-6. PubMed ID: 1424128
[TBL] [Abstract][Full Text] [Related]
4. Steady-state concentration of cyclosporin G (OG37-325) and its metabolites in renal transplant recipients.
Langman LJ; Leichtman AB; Weitzel WF; Yatscoff RW
Clin Chem; 1994 Apr; 40(4):613-6. PubMed ID: 8149619
[TBL] [Abstract][Full Text] [Related]
5. Progress report of an external quality assessment scheme for cyclosporine assay.
Zucchelli GC; Pilo A; Chiesa MR; Scarlattini M; Bizollon CA
Ther Drug Monit; 1996 Jun; 18(3):273-9. PubMed ID: 8738767
[TBL] [Abstract][Full Text] [Related]
6. The EMIT Cyclosporine Assay: development of application protocols for the Boehringer Mannheim Hitachi 911 and 917 analyzers.
Dias VC; Legatt DF; Yatscoff RW
Clin Biochem; 1997 Mar; 30(2):155-62. PubMed ID: 9127698
[TBL] [Abstract][Full Text] [Related]
7. Comparison of nonspecific radioimmunoassay, high-performance liquid chromatography, and fluorescence polarization immunoassay for cyclosporine monitoring in renal transplantation.
Lee SF; Yang WC; Shann TY; Lui WY; Wang RB
Ther Drug Monit; 1991 Mar; 13(2):152-6. PubMed ID: 2053123
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cyclosporin G (Nva2-cyclosporin) concentrations measured in whole blood by monoclonal fluorescence polarization immunoassay, monoclonal radioimmunoassay, and HPLC.
Annesley TM; Coombs RC; Orsulak PJ
Clin Chem; 1993 Jun; 39(6):1050-3. PubMed ID: 8504536
[TBL] [Abstract][Full Text] [Related]
9. Analytical evaluation of TDx cyclosporine and metabolites fluorescence polarization immunoassay and comparison with the Cyclo-Trac RIA kit.
Montojo C; Calvo MV; Domínguez-Gil A
J Clin Pharm Ther; 1990 Feb; 15(1):45-51. PubMed ID: 2180968
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients.
Schroeder TJ; Brunson ME; Pesce AJ; Hindenlang LL; Mauser PA; Ruckrigl DI; Weibel ML; Wadih G; First MR
Transplantation; 1989 Feb; 47(2):262-6. PubMed ID: 2645710
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic studies of cyclosporine in marrow transplant recipients. A comparison of three assay methods.
McGuire TR; Yee GC; Emerson S; Gmur DJ; Carlin J
Transplantation; 1992 Jun; 53(6):1272-5. PubMed ID: 1604484
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the TDx method for cyclosporine and a comparison to CYCLO-Trac RIA in renal transplant patients.
Vandenbroucke AC
Clin Biochem; 1988 Oct; 21(5):307-9. PubMed ID: 3069244
[TBL] [Abstract][Full Text] [Related]
13. A comparison of cyclosporine assays using sequential samples from selected transplant patients.
LeGatt DF; Coates JE; Simpson AI; Shalapay CE; Rintoul BJ; Yatscoff RW
Clin Biochem; 1994 Feb; 27(1):43-8. PubMed ID: 8200114
[TBL] [Abstract][Full Text] [Related]
14. Conversion of cardiac and liver transplant recipients from HPLC and FPIA (polyclonal) to an FPIA (monoclonal) technique for measurement of blood cyclosporin A.
McBride JH; Kim S; Rodgerson DO; Reyes A
J Clin Lab Anal; 1998; 12(6):337-42. PubMed ID: 9850184
[TBL] [Abstract][Full Text] [Related]
15. Comparative analyses of cyclosporine in whole blood and plasma by radioimmunoassay, fluorescence polarization immunoassay, and high-performance liquid chromatography.
Lindholm A; Henricsson S
Ther Drug Monit; 1990 Jul; 12(4):344-52. PubMed ID: 2396308
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.
Gruber SA; Gallichio M; Rosano TG; Kaplan SS; Hughes SE; Urbauer DL; Singh TP; Lempert N; Conti DJ; Stein DS; Drusano G
J Clin Pharmacol; 1997 Jul; 37(7):575-86. PubMed ID: 9243350
[TBL] [Abstract][Full Text] [Related]
17. Quality assurance program for cyclosporin G (OG37-325).
Yatscoff RW; Chackowsky P
Ther Drug Monit; 1995 Aug; 17(4):342-7. PubMed ID: 7482687
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactivities of cyclosporin G (NVa2 cyclosporin) and metabolites in cyclosporin A immunoassays.
Yatscoff RW; Langman LJ; LeGatt DF
Clin Chem; 1993 Jun; 39(6):1089-92. PubMed ID: 8504544
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the AxSYM monoclonal cyclosporin assay and comparison with radioimmunoassay.
Sabaté I; Ginard M; González JM; Baró E; Acebes G; Cuadros J; Lirón FJ
Ther Drug Monit; 2000 Aug; 22(4):474-80. PubMed ID: 10942190
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine A monitoring in patients with renal, cardiac, and liver transplants: a comparison between fluorescence polarization immunoassay and two different RIA methods.
Bergan S; Rugstad HE; Stokke O; Bentdal O; Frøysaker T; Bergan A
Scand J Clin Lab Invest; 1993 Aug; 53(5):471-7. PubMed ID: 8210969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
